ASTRAZEN.BO
ASTRAZEN.BO
INE203A01020
ASTRAZENECA PHARMA INDIA LTD.
Loading chart...

Company Profile

AstraZeneca Pharma India Limited, a biopharmaceutical company, manufactures, markets, and trades in pharmaceutical products in India and internationally. It provides medicines for cancers, including pancreatic cancer, certain blood cancers, and cancers within breast, lung, ovary, and prostate; rare diseases; and cardiovascular, renal and metabolism, and respiratory and immunology, as well as diabetes. The company serves distributors, hospitals, and government institutions. The company was incorporated in 1979 and is based in Bengaluru, India. AstraZeneca Pharma India Limited is a subsidiary of AstraZeneca Pharmaceuticals AB.

Related stocks

NATCOPHARM.NS
NATCOPHARM.NS • India
NATCO PHARMA LTD.
789.4 INR
1.5B USD 1Y -1.7%
APLLTD.NS
APLLTD.NS • India
ALEMBIC PHARMA LTD
800.95 INR
1.63B USD 1Y -14%
ALIVUS.NS
ALIVUS.NS • India
ALIVUS LIFE SCIENCES LTD
1,326.3 INR
1.68B USD 1Y +45.4%
JUBLPHARMA.BO
JUBLPHARMA.BO • India
JUBILANT PHARMOVA LIMITED
931.2 INR
1.52B USD 1Y -14.2%
SHILPAMED.BO
SHILPAMED.BO • India
SHILPA MEDICARE LTD.
1,020.35 INR
2.06B USD 1Y +187.4%
ERIS.NS
ERIS.NS • India
ERIS LIFESCIENCES LIMITED
1,170.7 INR
1.68B USD 1Y -27.8%
CAPLIPOINT.BO
CAPLIPOINT.BO • India
CAPLIN POINT LABORATORIES LTD.
2,459.55 INR
1.93B USD 1Y +27.1%
GRANULES.NS
GRANULES.NS • India
GRANULES INDIA LIMITED
815.25 INR
2.3B USD 1Y +48.5%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
33.8% p.a.
Max Drawdown (5Y)
-45.8%
Sharpe Ratio (5Y)
0.30
Beta Factor
0.23
Size Class
Mega Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 High valuation risk: Avg P/E of 86.0 (Elevated multiple compression risk)
Elevated Short-Term Volatility: 3Y volatility (38.0%) is noticeably higher than the 5Y average (33.8%).
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (33.8% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -47.3% in the extended horizon.
ende